IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending ...

In partnership with the University of Oxford’s Pandemic Sciences Institute, the grant will advance oral vaccine delivery.

Anocca AB ( Anocca ), a clinical-stage T-cell immunotherapy company, raised SEK ~440 million (USD ~46 million) in financing. Mellby Gård led the financing with strong support from AMF, Ramsbury, and ...

Systlmmune and BMS’ ACD treats patients with previously treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer.

Developed by Daiichi Sankyo and Merck, it treats patients with Pretreated Extensive-Stage Small Cell Lung Cancer.